体外受精和胚胎培养后囊胚滋养外胚层活检在小鼠模型中增加表观遗传失调
本研究利用小鼠模型评估体外受精(IVF)后囊胚滋养外胚层活检(TEBx)对胎盘、胚胎发育及子代代谢的影响,设置自然受孕、IVF、IVF+TEBx及IVF+TEBx+玻璃化冷冻组,在胚胎第12.5天和18.5天及12周龄子代中检测。结果显示TEBx在妊娠中期对胎盘和胚胎组织有更不利影响,胚胎组织改变持续或加重,且12周龄子代出现血糖、胰岛素、甘油三酯升高及总胆固醇、高密度脂蛋白降低。
要点
- TEBx在妊娠中期对胎盘和胚胎DNA甲基化及基因表达的影响较IVF单独更差
- TEBx后胚胎组织的分子改变在发育后期持续或加重
- 12周龄IVF+TEBx子代血糖、胰岛素、甘油三酯升高,总胆固醇和高密度脂蛋白降低
核心结论
- TEBx在妊娠中期对胎盘和胚胎组织有更不利影响,胚胎组织改变在后期持续或加重。
- TEBx后添加玻璃化冷冻导致更明显且可能有害的表观遗传效应。
- 12周龄IVF+TEBx子代显示血糖、胰岛素、甘油三酯升高,总胆固醇和高密度脂蛋白降低。
研究设计与样本
- 采用小鼠模型,CF-1雌鼠为卵母细胞供体,SJL/B6雄鼠为精子供体。
- 评估自然受孕、IVF、IVF+TEBx三组在胚胎第12.5天(n=40/自然、n=36/IVF、n=36/IVF+TEBx)和胚胎第18.5天(n=42/自然、n=30/IVF、n=35/IVF+TEBx)。
- 另设IVF+TEBx+玻璃化冷冻组在胚胎第12.5天(n=29)。
- 12周龄子代队列:n=24/自然、n=25/IVF、n=25/IVF+TEBx。
主要发现
- 胚胎第12.5天,IVF+TEBx组胎盘和全胚胎DNA甲基化及差异基因表达改变较IVF单独和自然受孕组更差。
- 上述改变反映在胎盘形态和血管密度变化上。
- 胚胎第18.5天,胎儿早期分子改变维持或加剧;胎盘分子和形态改变与IVF组相当,但血管密度改变持续。
- 多数差异具有性别特异性。
- 12周龄IVF+TEBx子代(不分性别)血糖、胰岛素、甘油三酯升高,总胆固醇和高密度脂蛋白降低;仅雄性体重高于IVF和自然受孕组。
临床怎么用
- 作者认为,小鼠模型发现支持需要更多研究评估辅助生殖技术新操作对健康妊娠和子代结局的影响。
- 作者指出,本研究强调应检测辅助生殖技术中新操作对胎盘、胚胎发育及子代代谢结局的影响。
局限性
- 本研究使用小鼠模型模拟许多临床IVF操作和人类观察到的结局,但无法在人类早期胚胎上进行研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Does trophectoderm biopsy (TEBx) of blastocysts for preimplantation genetic testing in the clinic affect normal placental and embryo development and offspring metabolic outcomes in a mouse model? SUMMARY ANSWER: TEBx impacts placental and embryonic health during early development, with some alterations resolving and others worsening later in development and triggering metabolic changes in adult offspring. WHAT IS KNOWN ALREADY: Previous studies have not assessed the epigenetic and morphological impacts of TEBx either in human populations or in animal models. STUDY DESIGN, SIZE, DURATION: We employed a mouse model to identify the effects of TEBx during IVF. Three groups were assessed: naturally conceived (Naturals), IVF, and IVF + TEBx, at two developmental timepoints: embryonic day (E)12.5 (n = 40/Naturals, n = 36/IVF, and n = 36/IVF + TEBx) and E18.5 (n = 42/Naturals, n = 30/IVF, and n = 35/IVF + TEBx). Additionally, to mimic clinical practice, we assessed a fourth group: IVF + TEBx + Vitrification (Vit) at E12.5 (n = 29) that combines TEBx and vitrification. To assess the effect of TEBx in offspring health, we characterized a 12-week-old cohort (n = 24/Naturals, n = 25/IVF and n = 25/IVF + TEBx). PARTICIPANTS/MATERIALS, SETTING, METHODS: Our mouse model used CF-1 females as egg donors and SJL/B6 males as sperm donors. IVF, TEBx, and vitrification were performed using standardized methods. Placenta morphology was evaluated by hematoxylin-eosin staining, in situ hybridization using Tpbpa as a junctional zone marker and immunohistochemistry using CD34 fetal endothelial cell markers. For molecular analysis of placentas and embryos, DNA methylation was analyzed using pyrosequencing, luminometric methylation assay, and chip array technology. Expression patterns were ascertained by RNA sequencing. Triglycerides, total cholesterol, high-, low-, and very low-density lipoprotein, insulin, and glucose were determined in the 12-week-old cohort using commercially available kits. MAIN RESULTS AND THE ROLE OF CHANCE: We observed that at E12.5, IVF + TEBx had a worse outcome in terms of changes in DNA methylation and differential gene expression in placentas and whole embryos compared with IVF alone and compared with Naturals. These changes were reflected in alterations in placental morphology and blood vessel density. At E18.5, early molecular changes in fetuses were maintained or exacerbated. With respect to placentas, the molecular and morphological changes, although different compared to Naturals, were equivalent to the IVF group, except for changes in blood vessel density, which persisted. Of note is that most differences were sex specific. We conclude that TEBx has more detrimental effects in mid-gestation placental and embryonic tissues, with alterations in embryonic tissues persisting or worsening in later developmental stages compared to IVF alone, and the addition of vitrification after TEBx results in more pronounced and potentially detrimental epigenetic effects: these changes are significantly different compared to Naturals. Finally, we observed that 12-week IVF + TEBx offspring, regardless of sex, showed higher glucose, insulin, triglycerides, lower total cholesterol, and lower high-density lipoprotein compared to IVF and Naturals, with only males having higher body weight compared to IVF and Naturals. Our findings in a mouse model additionally support the need for more studies to assess the impact of new procedures in ART to ensure healthy pregnancies and offspring outcomes. LARGE SCALE DATA: Data reported in this work have been deposited in the NCBI Gene Expression Omnibus under accession number GSE225318. LIMITATIONS, REASONS FOR CAUTION: This study was performed using a mouse model that mimics many clinical IVF procedures and outcomes observed in humans, where studies on early embryos are not possible. WIDER IMPLICATIONS OF THE FINDINGS: This study highlights the importance of assaying new procedures used in ART to assess their impact on placenta and embryo development, and offspring metabolic outcomes. STUDY FUNDING/COMPETING INTEREST(S): This work was funded by a National Centers for Translational Research in Reproduction and Infertility grant P50 HD068157-06A1 (M.S.B., C.C., M.M.), Ruth L. Kirschstein National Service Award Individual Postdoctoral Fellowship F32 HD107914 (E.A.R.-C.) and F32 HD089623 (L.A.V.), and National Institutes of Health Training program in Cell and Molecular Biology T32 GM007229 (C.N.H.). No conflict of interest.
引用
- Rhon-Calderon EA, Hemphill CN, Vrooman LA, et al. Trophectoderm biopsy of blastocysts following IVF and embryo culture increases epigenetic dysregulation in a mouse model. Hum Reprod. 2024. PMID: 37994669. doi:10.1093/humrep/dead238
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。